Carl Zeiss Meditec AG (ETR:AFX)

Revenue by Geography

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
EMEA Revenue	673.20M	657.50M	584.30M
EMEA Revenue Growth	2.39%	12.53%	12.95%
Americas Revenue	548.20M	579.20M	532.90M
Americas Revenue Growth	-5.35%	8.69%	-6.62%
APAC Revenue	946.70M	991.00M	949.00M
APAC Revenue Growth	-4.47%	4.43%	-5.21%
Revenue (Other)	80.00K	-50.00K	-70.00K
Revenue (Total)	2.17B	2.23B	2.07B
Revenue (Total) Growth	-2.67%	7.82%	-1.11%

Revenue by Geography 2

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Germany Revenue	-	1.29B	1.23B
Germany Revenue Growth	-	4.92%	-2.49%
North America Revenue	-	552.66M	522.32M
North America Revenue Growth	-	5.81%	-8.11%
Asia Revenue	-	86.07M	83.33M
Asia Revenue Growth	-	3.29%	-16.40%
Europe excl. Germany Revenue	-	294.18M	226.47M
Europe excl. Germany Revenue Growth	-	29.90%	45.43%
Revenue (Total)	2.17B	2.23B	2.07B
Revenue (Total) Growth	-2.67%	7.82%	-1.11%

Revenue

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Ophthalmology Revenue	1.67B	1.72B	1.59B
Ophthalmology Revenue Growth	-3.16%	8.47%	0.80%
Microsurgery Revenue	498.88M	503.94M	476.96M
Microsurgery Revenue Growth	-1.00%	5.66%	-6.99%
Revenue (Other)	30.00K	2.00K	5.00K
Revenue (Total)	2.17B	2.23B	2.07B
Revenue (Total) Growth	-2.67%	7.82%	-1.11%

Gross Profit

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Ophthalmology Gross Profit	-	897.88M	802.21M
Ophthalmology Gross Profit Growth	-	11.93%	-9.53%
Microsurgery Gross Profit	-	277.32M	286.42M
Microsurgery Gross Profit Growth	-	-3.18%	-10.22%
Gross Profit (Total)	1.11B	1.18B	1.09B
Gross Profit (Total) Growth	-5.39%	7.95%	-9.71%

EBITDA

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Ophthalmology EBITA	-	187.19M	153.28M
Ophthalmology EBITA Growth	-	22.13%	-
Microsurgery EBITA	-	70.56M	95.61M
Microsurgery EBITA Growth	-	-26.20%	-
Operating Income (Total)	149.19M	223.32M	194.45M
Operating Income (Total) Growth	-33.20%	14.85%	-44.14%

EBIT

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Ophthalmology Earnings Before Interest and Taxes	92.33M	154.32M	100.43M
Ophthalmology Earnings Before Interest and Taxes Growth	-40.17%	53.66%	-54.07%
Microsurgery Earnings Before Interest and Taxes	56.86M	69.00M	94.02M
Microsurgery Earnings Before Interest and Taxes Growth	-17.61%	-26.61%	-27.39%
Operating Income (Other)	7.00K	-	-
Operating Income (Total)	149.19M	223.32M	194.45M
Operating Income (Total) Growth	-33.20%	14.85%	-44.14%

Key Performance Indicators

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Order Backlog	379.65M	282.86M
Order Backlog Growth	34.22%	-30.82%

Updated May 13, 2026. Data Source: Fiscal.ai.